The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey.
The impact of coronavirus disease 2019 (COVID-19) on the antimicrobial stewardship pharmacist workforce: A multicenter survey.
复制标题
DOI：
10.1017/ash.2022.37
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Pulia, Michael S
中科院分区：
文献类型：
--
作者：
Wimmer, Megan R;Schulz, Lucas T;Hamel, Ashlee G;Schwei, Rebecca J;Fong, Karen;Burgess, Donna R;Brett, Meghan;Hale, Cory M;Holubar, Marisa;Jain, Rupali;Larry, Rachel;Spivak, Emily S;Newland, Helen;Njoku, Jessica;Postelnick, Michael;Walraven, Carla;Pulia, Michael S
2019 年冠状病毒病 (COVID-19) 大流行要求医疗保健系统和医院迅速修改标准做法，包括抗菌药物管理服务。我们的研究探讨了 COVID-19 对抗菌药物管理药剂师的影响。一项调查在全国范围内分发给所有医疗保健改善公司成员。药剂师参与者大多是抗菌药物管理项目的领导者，均匀分布在美国各地，代表城市、郊区和农村卫生系统实践场所。参与者报告说，与大流行之前相比，在 COVID-19 大流行期间，完成与药物获取和预授权相关的任务的时间 (300%；P = .018) 以及行政会议时间 (34%；P = .067) 相对增加。查房、进行干预、执行药代动力学服务和药物协调所花费的时间减少了。远离临床活动可能会对抗菌药物的使用产生负面影响。
The coronavirus disease 2019 (COVID-19) pandemic has required healthcare systems and hospitals to rapidly modify standard practice, including antimicrobial stewardship services. Our study examines the impact of COVID-19 on the antimicrobial stewardship pharmacist. A survey was distributed nationally to all healthcare improvement company members. Pharmacist participants were mostly leaders of antimicrobial stewardship programs distributed evenly across the United States and representing urban, suburban, and rural health-system practice sites. Participants reported relative increases in time spent completing tasks related to medication access and preauthorization (300%; P = .018) and administrative meeting time (34%; P = .067) during the COVID-19 pandemic compared to before the pandemic. Time spent rounding, making interventions, performing pharmacokinetic services, and medication reconciliation decreased. A shift away from clinical activities may negatively affect the utilization of antimicrobials.